A team from the Research Institute of the McGill University Health Center (The Institute), led by Jean-Jacques Lebrun, Ph.D., ...

Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found ...

Breast cancer remains one of the most prevalent malignancies worldwide, with approximately 2.3 million new cases diagnosed annually. Cytokines - small ...

Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

Druggable phosphatases in cancer and immune cells, with examples of their corresponding drugs. Structures of allosteric inhibitors targeting PP2A, PRL3, DUSP1/6, and SHP2 in cancer cells (left).

This Research Topic focuses on cancers originating outside the central nervous system across the lifespan (including paediatric, adolescent, and adult ...

A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...